If the lending group is happier dealing with Cupric because they have the financial backing & expertise better suited to managing competently DML's valuable assets, then so be it.
Having said that, Cupric must offer a fair price for shareholder equity. Transamine we assume is still holding the parcel they bought last
May @ .0345c & ( as far as we know ) , Blumont is still a holder having only sold half their holdings (as per ASX releases) in the last few weeks. The price paid for their holding was 12c.
The directors had no option but to place the company in VA given the circumstances, let's hope the administrators can negotiate well on behalf of the equity holders.
DML Price at posting:
1.9¢ Sentiment: Hold Disclosure: Held
